News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
553,168 Results
Type
Article (36969)
Company Profile (244)
Press Release (515946)
Multimedia
Podcasts (101)
Webinars (11)
Section
Business (151646)
Career Advice (820)
Deals (26199)
Drug Delivery (84)
Drug Development (67338)
Employer Resources (72)
FDA (12795)
Job Trends (11149)
News (258244)
Policy (20467)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2083)
Academic (1)
Accelerated approval (26)
Adcomms (22)
Allergies (102)
Alliances (43702)
ALS (132)
Alzheimer's disease (1439)
Antibody-drug conjugate (ADC) (342)
Approvals (13074)
Artificial intelligence (528)
Autoimmune disease (141)
Automation (33)
Bankruptcy (199)
Best Places to Work (9436)
BIOSECURE Act (14)
Biosimilars (131)
Biotechnology (189)
Bladder cancer (164)
Brain cancer (63)
Breast cancer (671)
Cancer (5048)
Cardiovascular disease (307)
Career advice (710)
Career pathing (17)
CAR-T (294)
CDC (25)
Celiac Disease (2)
Cell therapy (739)
Cervical cancer (38)
Clinical research (57370)
Collaboration (1668)
Company closure (4)
Compensation (784)
Complete response letters (40)
COVID-19 (1880)
CRISPR (94)
C-suite (710)
Cystic fibrosis (117)
Data (5639)
Decentralized trials (2)
Denatured (31)
Depression (86)
Diabetes (374)
Diagnostics (6370)
Digital health (39)
Diversity (10)
Diversity, equity & inclusion (14)
Drug discovery (241)
Drug pricing (99)
Drug shortages (9)
Duchenne muscular dystrophy (156)
Earnings (59523)
Editorial (26)
Employer branding (10)
Employer resources (66)
Events (87057)
Executive appointments (823)
FDA (15508)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (7)
Frontotemporal dementia (20)
Funding (1361)
Gene editing (202)
Generative AI (47)
Gene therapy (510)
GLP-1 (700)
Government (2591)
Grass and pollen (3)
Guidances (329)
Healthcare (14613)
HIV (46)
Huntington's disease (35)
IgA nephropathy (77)
Immunology and inflammation (243)
Immuno-oncology (60)
Indications (93)
Infectious disease (2099)
Inflammatory bowel disease (179)
Inflation Reduction Act (11)
Influenza (95)
Intellectual property (226)
Interviews (105)
IPO (12594)
IRA (30)
Job creations (2105)
Job search strategy (596)
JPM (49)
Kidney cancer (16)
Labor market (35)
Layoffs (352)
Leadership (16)
Legal (3897)
Liver cancer (99)
Longevity (10)
Lung cancer (682)
Lymphoma (374)
Machine learning (41)
Management (27)
Manufacturing (640)
MASH (134)
Medical device (12430)
Medtech (12482)
Mergers & acquisitions (14566)
Metabolic disorders (954)
Multiple sclerosis (133)
NASH (14)
Neurodegenerative disease (263)
Neuropsychiatric disorders (63)
Neuroscience (2417)
Neurotech (1)
NextGen: Class of 2026 (4827)
Non-profit (2956)
Now hiring (23)
Obesity (404)
Opinion (200)
Ovarian cancer (169)
Pain (184)
Pancreatic cancer (234)
Parkinson's disease (240)
Partnered (27)
Patents (447)
Patient recruitment (446)
Peanut (41)
People (44965)
Pharmaceutical (39)
Pharmacy benefit managers (18)
Phase 1 (19711)
Phase 2 (25499)
Phase 3 (17769)
Pipeline (4607)
Policy (158)
Postmarket research (1589)
Preclinical (8416)
Press Release (67)
Prostate cancer (251)
Psychedelics (24)
Radiopharmaceuticals (292)
Rare diseases (682)
Real estate (4108)
Recruiting (31)
Regulatory (17508)
Reports (25)
Research institute (2143)
Resumes & cover letters (165)
Rett syndrome (25)
RNA editing (19)
RSV (62)
Schizophrenia (116)
Series A (238)
Series B (170)
Service/supplier (6)
Sickle cell disease (81)
Special edition (9)
Spinal muscular atrophy (119)
Sponsored (35)
Startups (3167)
State (2)
Stomach cancer (20)
Supply chain (65)
Tariffs (39)
The Weekly (68)
Vaccines (755)
Venture capital (69)
Weight loss (227)
Women's health (59)
Worklife (5)
Date
Last 7 days (482)
Last 30 days (1689)
Last 365 days (25963)
2026 (2416)
2025 (26396)
2024 (30684)
2023 (34928)
2022 (44744)
2021 (47427)
2020 (43736)
2019 (36226)
2018 (27036)
2017 (26696)
2016 (25142)
2015 (29201)
2014 (22004)
2013 (18152)
2012 (19443)
2011 (19765)
2010 (18348)
Location
Africa (458)
Alabama (81)
Alaska (6)
Arizona (220)
Arkansas (13)
Asia (34537)
Australia (6077)
California (9842)
Canada (2553)
China (1047)
Colorado (388)
Connecticut (428)
Delaware (279)
Europe (75936)
Florida (1459)
Georgia (308)
Hawaii (3)
Idaho (42)
Illinois (702)
India (46)
Indiana (479)
Iowa (18)
Japan (394)
Kansas (113)
Kentucky (34)
Louisiana (20)
Maine (60)
Maryland (1144)
Massachusetts (7024)
Michigan (296)
Minnesota (516)
Mississippi (6)
Missouri (125)
Montana (28)
Nebraska (15)
Nevada (83)
New Hampshire (84)
New Jersey (2476)
New Mexico (28)
New York (2579)
North Carolina (1176)
North Dakota (9)
Northern California (4775)
Ohio (253)
Oklahoma (17)
Oregon (42)
Pennsylvania (1819)
Puerto Rico (20)
Rhode Island (38)
South America (669)
South Carolina (61)
South Dakota (1)
Southern California (3872)
Tennessee (135)
Texas (1603)
United States (34308)
Utah (280)
Vermont (1)
Virginia (222)
Washington D.C. (37)
Washington State (824)
West Virginia (4)
Wisconsin (113)
Wyoming (1)
553,168 Results for "cancer targeted technology".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
SU2C DREAM TEAM TARGETS EARLY DETECTION OF GASTRIC CANCER
January 9, 2026
·
7 min read
Press Releases
Immuto Scientific and University of Wisconsin–Madison Announce Collaboration to Advance Discovery of Novel Cancer Targets
January 30, 2026
·
3 min read
Press Releases
DISCO Pharmaceuticals Enters License Agreement to Advance Novel Cancer Surfaceome Targeted Therapies
January 7, 2026
·
2 min read
Press Releases
TellDx-Enabled Circulating Tumor Cell Analysis Predicts Response to DLL3-Targeted Therapy in Small Cell Lung Cancer
January 15, 2026
·
3 min read
Press Releases
Boehringer Ingelheim announces clinical collaboration with Jazz Pharmaceuticals to advance HER2-targeted therapy in breast cancer
January 12, 2026
·
3 min read
Press Releases
Faron Announces Strategic Collaboration with The Institute for Cancer Research to Launch BLAZE Trial, Targeting Immunotherapy Resistance in Cancer
December 22, 2025
·
5 min read
Press Releases
MAIA Biotechnology Advances Ateganosine Cancer Treatment Program, Outlines Targeted 2026 Clinical Milestones and Growth Momentum
January 21, 2026
·
7 min read
Press Releases
Theralase(R) Provides Update on Bladder Cancer Clinical Study
Interim clinical data has exceeded the recommended guidelines of the International Bladder Cancer Group for complete response and duration of complete response
February 4, 2026
·
7 min read
Press Releases
Privo Technologies Begins Dosing PRV131 in Arm 3 Of Clinical Study CLN-004, A First-In-Class Cisplatin Intratumoral Injectable Targeting Oral Cavity Cancer
December 11, 2025
·
3 min read
Press Releases
FDA and EMA Grant Orphan Drug Designation for Curadel’s CPI-008, a Targeted Zwitterionic Imaging Drug for Pancreatic Cancer
January 8, 2026
·
2 min read
1 of 55,317
Next
